(2S,3S,4S,5R,6S)-6-(((R)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochroman-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; (2R)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl beta-D-glucopyranosiduronic acid;(R)-2-(3,4-dihydroxyphenyl)-2,4-dihydro-5-hydroxy-4-oxo-2H-1-benzopyran-7-yl beta-D-glucopyranosiduronic acid;Eriodictyol 7-O-beta-D-glucuronide;(2R)-3',4',5-Trihydroxy-7-(beta-D-glucopyranuronosyloxy)flavanone;2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl hexopyranosiduronic acid;beta-D-Glucopyranosiduronic acid, 2-(3,4-dihydroxyphenyl)-2,4-dihydro-5-hydroxy-4-oxo-2H-1-benzopyran-7-yl, (R)-
Eriodictyol-7-O-Glucuronide is a fully characterized chemical compound used as a reference standard of API Eriodictyol. The standard offered is compliant with regulatory guidelines. Eriodictyol-7-O-Glucuronide is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 133360-47-1
